These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1830478)

  • 1. Kinetic studies of human polymorphonuclear leukocyte phosphofructokinase.
    Campos G; Ryder E; Morales LM; Raleigh X
    Biochem Biophys Res Commun; 1991 Jul; 178(2):672-8. PubMed ID: 1830478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isozyme analysis of human polymorphonuclear leukocyte phosphofructokinase from insulin resistant individuals.
    Durante P; Raleigh X; Gómez ME; Campos G; Ryder E
    Biochem Biophys Res Commun; 1996 Aug; 225(3):975-82. PubMed ID: 8780720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isozyme analysis of human normal polymorphonuclear leukocyte phosphofructokinase.
    Durante P; Raleigh X; Gómez ME; Campos G; Ryder E
    Biochem Biophys Res Commun; 1995 Nov; 216(3):898-905. PubMed ID: 7488210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of adrenal steroids on human erythrocyte phosphofructokinase.
    Kwiatkowska D; Szechiński J
    Arch Immunol Ther Exp (Warsz); 1986; 34(4):445-50. PubMed ID: 2948478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of free Mg2+ on the kinetics of human erythrocyte phosphofructokinase.
    Etiemble J; Simeon J; Picat C; Boivin P
    Biochimie; 1981 Jan; 63(1):61-5. PubMed ID: 6452173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citrate inhibition of rat-kidney cortex phosphofructokinase.
    Sola MM; Oliver FJ; Salto R; Gutiérrez M; Vargas A
    Mol Cell Biochem; 1994 Jun; 135(2):123-8. PubMed ID: 7838139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of muscle phosphofructokinase by alpha-glucose 1,6-bisphosphate and fructose 2,6-bisphosphate is differently affected by other allosteric effectors and by pH.
    Andrés V; Carreras J; Cussó R
    Biochem Biophys Res Commun; 1988 Dec; 157(2):664-9. PubMed ID: 2974284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subunit composition, regulatory properties, and phosphorylation of phosphofructokinase from human gliomas.
    Staal GE; Kalff A; Heesbeen EC; van Veelen CW; Rijksen G
    Cancer Res; 1987 Oct; 47(19):5047-51. PubMed ID: 2957049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic effects of fructose-1,6-bisphosphate on yeast phosphofructokinase.
    Otto A; Przybylski F; Nissler K; Schellenberger W; Hofmann E
    Biomed Biochim Acta; 1986; 45(7):865-75. PubMed ID: 2947575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphofructokinase control in muscle: nature and reversal of pH-dependent ATP inhibition.
    Dobson GP; Yamamoto E; Hochachka PW
    Am J Physiol; 1986 Jan; 250(1 Pt 2):R71-6. PubMed ID: 2934994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of phosphofructokinase from granulocytes isolated from patients with insulin resistance.
    Campos G; Ryder E; Morales LM; Raleigh X
    Biochem Biophys Res Commun; 1992 Jun; 185(2):559-66. PubMed ID: 1535194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of phosphofructokinase at physiological concentration of enzyme studied by stopped-flow measurements.
    Bär J; Martínez-Costa OH; Aragón JJ
    Biochem Biophys Res Commun; 1990 Mar; 167(3):1214-20. PubMed ID: 2138893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-linked alterations in fructose-2,6-bisphosphate-induced modulation of rat muscle phosphofructokinase.
    Trigun SK; Singh SN
    Biochem Int; 1989 Dec; 19(6):1213-21. PubMed ID: 2534568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of muscle phosphofructokinase by physiological concentrations of bisphosphorylated hexoses: effect of alkalinization.
    Andrés V; Carreras J; Cussó R
    Biochem Biophys Res Commun; 1990 Oct; 172(1):328-34. PubMed ID: 2145837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast phosphofructokinase: kinetic characterization of a substrate-imprinted enzyme conformation.
    Kriegel T; Schellenberger W; Kopperschläger G; Hofmann E
    Biomed Biochim Acta; 1991; 50(12):1159-65. PubMed ID: 1840474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reaction mechanism of erythrocyte phosphofructokinase.
    Etiemble J; Picat C; Boivin P
    Biochimie; 1977; 59(8-9):673-8. PubMed ID: 145878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphofructokinase 2: the enzyme that forms fructose 2,6-bisphosphate from fructose 6-phosphate and ATP.
    Van Schaftingen E; Hers HG
    Biochem Biophys Res Commun; 1981 Aug; 101(3):1078-84. PubMed ID: 6458291
    [No Abstract]   [Full Text] [Related]  

  • 18. Partial purification and regulatory properties of phosphofructokinase from Aspergillus niger.
    Habison A; Kubicek CP; Röhr M
    Biochem J; 1983 Mar; 209(3):669-76. PubMed ID: 6223622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Properties of erythrocyte phosphofructokinase in normal humans].
    Mandereau J; Boivin P
    Biochimie; 1973; 55(11):1341-51. PubMed ID: 4364375
    [No Abstract]   [Full Text] [Related]  

  • 20. Yeast phosphofructokinase: pre-steady-state and stationary kinetic studies on a cross-linked enzyme form.
    Kriegel T; Bär J; Schellenberger W; König S; Behlke J; Hübner G; Kopperschläger G
    Biomed Biochim Acta; 1990; 49(5):317-25. PubMed ID: 2148671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.